Sign inCreate account

Report workspace tools

NCT07352410COMPLETEDanonymous

Safety and Early Clinical Performance of High-Purity Type I Collagen Augmentation in Arthroscopic Meniscal Repair: A Prospective Feasibility Study

Sponsor

Source record

Adichunchanagiri Institute of Medical Sciences, B G Nagara

Phase

Source record

NA

Modality

AI-normalized

medical device

Target

AI-normalized

High-Purity Type I Collagen

Indication / condition

AI-normalized

Meniscus Tear

Intervention

Source record

High-Purity Type I Collagen

Source & freshness

Source record

NCT ID

NCT07352410

Original source

ClinicalTrials.gov

Source last updated

Apr 08, 2026

Ingested at

Jun 11, 2026

Internal sync

Jun 11, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT07352410

Title

Safety and Early Clinical Performance of High-Purity Type I Collagen Augmentation in Arthroscopic Meniscal Repair: A Prospective Feasibility Study

Sponsor

Adichunchanagiri Institute of Medical Sciences, B G Nagara

Status

COMPLETED

Phase

NA

Condition raw

Meniscus Tear, Knee Meniscus Injury, Meniscal Repair, Knee Arthroscopy (for Diagnostic or Therapy)

Condition normalized

Meniscus Tear, Knee Meniscus Injury, Meniscal Repair, Knee Arthroscopy (for Diagnostic or Therapy)

Modality raw

medical device

Modality normalized

medical device

Target raw

High-Purity Type I Collagen

Target normalized

High-Purity Type I Collagen

Interventions

High-Purity Type I Collagen

Public preview

Source record

This prospective, single-arm feasibility study evaluates the safety, procedural feasibility, and early clinical outcomes of High-Purity Type I Collagen used as an adjunct in arthroscopic meniscal repair. The study aims to generate preliminary clinical, functional, and imaging data to inform the design of a future randomized controlled trial.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Safety and Early Clinical Performance of High-Purity Type I Collagen Augmentation in Arthroscopic Meniscal Repair: A Prospective Feasibility Study

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT07352410

Status

COMPLETED

Phase

NA

Sponsor

Adichunchanagiri Institute of Medical Sciences, B G Nagara

Executive brief

Investment-Ready Snapshot

This prospective, single-arm feasibility study evaluates the safety, procedural feasibility, and early clinical outcomes of High-Purity Type I Collagen used as an adjunct in arthroscopic meniscal repair. The study aims to generate preliminary clinical, functional, and imaging data to inform the design of a future randomized controlled trial.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedApr 08, 2026
Internal syncJun 11, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT07352410

Indication

Meniscus Tear

Modality

medical device

Target

High-Purity Type I Collagen

Intervention

High-Purity Type I Collagen

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.